surmount-osa trial tirzepatide results on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the randomized Tirzepatide in Obesity-Related Obstructive Sleep
Pay in 4 interest-free payments of $6.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30



























